STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more
Ed Silverman·
·1 min read
·
0 reactions
·
0 comments
·
16 views
Biogen and Denali said their experimental Parkinson’s therapy failed to slow the degenerative brain disorder in a randomized trial
Original article
STAT · Ed Silverman
Anonymous · no account needed
Discussion
0 commentsMore from STAT
WHO director-general is profoundly concerned after visit to Ebola outbreak area
STAT·8
Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73
STAT·12
Nonprofit buys experimental cancer drug to maintain patient access
STAT·13
Study highlights influence of socioeconomic status on children’s brain development
STAT·11
STAT+: Abridge inks deals with Nvidia and Lilly
STAT·11
STAT+: Novartis doubles down on molecular glue strategy
STAT·12